ArticleJournal of clinical medicine2019

A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer.

Hariprasad Thangavel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.